Document is current
Any future updates will be listed below
-
Authors
Duus, Camilla L. https://orcid.org/0009-0007-2241-5791
Nielsen, Steffen F. https://orcid.org/0009-0002-5410-1088
Lyksholm, Trine Z.
Mose, Frank H.
Bech, Jesper N.
-
Funding
Funding for this research was provided by:
Augustinus Fonden
Health Research Fund of Central Denmark Region
Arvid Nilssons Fond
Dansk Nefrologisk Selskab
Nyreforeningen
- License Information
-
More Information
Article History
Received: 10 June 2025
Revised: 13 November 2025
Accepted: 24 November 2025
First Online: 4 December 2025
Competing interests
: CLD and TZL: NONE. SFN: Has had travel expenses for a congress reimbursed by Astra-Zeneca. FHM: Has received teaching fees from Boehringer-Ingelheim and Novo Nordisk. JNB: Advisory boards Bayer and AstraZeneca; travel reimbursement from AstraZeneca.
